FDC Drugs: Delhi HC lifts ban on Combikit used for syndromic management of STDs

FDC Drugs: Delhi HC lifts ban on Combikit used for syndromic management of STDs
Published on
2 min read

In one of several challenges to the ban on the manufacture, sale or distribution of Fixed Dose Combination (FDC) drugs in India, the Delhi High Court has set aside the notification banning the Combikit of Azithromycin, Secnidazole and Fluconazol.

Loading content, please wait...
Bar and Bench - Indian Legal news
www.barandbench.com